Table 2.
Correlation between clinicopathologic factors and TFPI-2 expression
| Characteristics | n | TFPI-2 | P | ||||
| - | + | ++ | +++ | ++++ | |||
| normal | 12 | 0 | 0 | 0 | 2 | 10 | < 0.001 |
| CIN | 48 | 0 | 3 | 19 | 18 | 8 | |
| CIN I | 21 | 0 | 0 | 3 | 10 | 8 | < 0.001 |
| CIN II/III | 27 | 0 | 3 | 16 | 8 | 0 | |
| ICC | 68 | 23 | 25 | 19 | 1 | 0 | |
| WICC | 13 | 2 | 5 | 6 | 0 | 0 | 0.474 |
| MICC | 39 | 13 | 15 | 10 | 1 | 0 | |
| PICC | 16 | 8 | 5 | 3 | 0 | 0 | |
| Histology | |||||||
| SCC | 61 | 19 | 22 | 19 | 1 | 0 | 0.304 |
| ACC | 7 | 4 | 3 | 0 | 0 | 0 | |
| Figo stage | |||||||
| I | 37 | 5 | 17 | 13 | 1 | 0 | 0.003 |
| II | 31 | 18 | 8 | 6 | 0 | 0 | |
| LN metastasis | |||||||
| Absent | 51 | 13 | 19 | 18 | 1 | 0 | 0.037 |
| Present | 17 | 10 | 6 | 1 | 0 | 0 | |
| HPV status | |||||||
| Absent | 38 | 1 | 6 | 9 | 9 | 13 | < 0.001 |
| Present | 90 | 26 | 22 | 25 | 12 | 5 | |